Not Valid for Submission
E34.5 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of androgen insensitivity syndrome. The code is not specific and is NOT valid for the year 2022 for the submission of HIPAA-covered transactions. Category or Header define the heading of a category of codes that may be further subdivided by the use of 4th, 5th, 6th or 7th characters.
Specific Coding for Androgen insensitivity syndrome
Non-specific codes like E34.5 require more digits to indicate the appropriate level of specificity. Consider using any of the following ICD-10 codes with a higher level of specificity when coding for androgen insensitivity syndrome:
- ANDROGEN INSENSITIVITY SYNDROME-. a disorder of sexual development transmitted as an x linked recessive trait. these patients have a karyotype of 46xy with end organ resistance to androgen due to mutations in the androgen receptor receptors androgen gene. severity of the defect in receptor quantity or quality correlates with their phenotypes. in these genetic males the phenotypic spectrum ranges from those with normal female external genitalia through those with genital ambiguity as in reifenstein syndrome to that of a normal male with infertility.
Information for Patients
Your endocrine system includes eight major glands throughout your body. These glands make hormones. Hormones are chemical messengers. They travel through your bloodstream to tissues or organs. Hormones work slowly and affect body processes from head to toe. These include
- Growth and development
- Metabolism - digestion, elimination, breathing, blood circulation and maintaining body temperature
- Sexual function
If your hormone levels are too high or too low, you may have a hormone disorder. Hormone diseases also occur if your body does not respond to hormones the way it is supposed to. Stress, infection and changes in your blood's fluid and electrolyte balance can also influence hormone levels.
In the United States, the most common endocrine disease is diabetes. There are many others. They are usually treated by controlling how much hormone your body makes. Hormone supplements can help if the problem is too little of a hormone.
[Learn More in MedlinePlus]
Androgen insensitivity syndrome
Androgen insensitivity syndrome is a condition that affects sexual development before birth and during puberty. People with this condition are genetically male, with one X chromosome and one Y chromosome in each cell. Because their bodies are unable to respond to certain male sex hormones (called androgens), they may have mostly female external sex characteristics or signs of both male and female sexual development.
Complete androgen insensitivity syndrome occurs when the body cannot use androgens at all. People with this form of the condition have the external sex characteristics of females, but do not have a uterus and therefore do not menstruate and are unable to conceive a child (infertile). They are typically raised as females and have a female gender identity. Affected individuals have male internal sex organs (testes) that are undescended, which means they are abnormally located in the pelvis or abdomen. Undescended testes have a small chance of becoming cancerous later in life if they are not surgically removed. People with complete androgen insensitivity syndrome also have sparse or absent hair in the pubic area and under the arms.
The partial and mild forms of androgen insensitivity syndrome result when the body's tissues are partially sensitive to the effects of androgens. People with partial androgen insensitivity (also called Reifenstein syndrome) can have genitalia that look typically female, genitalia that have both male and female characteristics, or genitalia that look typically male. They may be raised as males or as females and may have a male or a female gender identity. People with mild androgen insensitivity are born with male sex characteristics, but they are often infertile and tend to experience breast enlargement at puberty.
[Learn More in MedlinePlus]